Skip to Main Content

Paper Details

Tolerance doses for late adverse events after hypofractionated radiotherapy for prostate cancer on trial NRG Oncology/RTOG 0415.
Radiother Oncol
20
2019
gastrointestinal and genitourinary, low-risk prostate cancer, prostate cancer
Author NameAffiliation
William Robert LeeDuke University Medical Center
Deborah W BrunerEmory University/Winship Cancer Institute
Daniel A Lowuniversity of california los angeles
Jeff M MichalskiWashington University
Thomas M PisanskyMayo Clinic
Bridget F KoontzDuke University Medical Center
Stephanie L Pugh
Howard M SandlerCedars-Sinai Medical Center
  • 1 - 8

Datasets

Release 1.2